351
Views
16
CrossRef citations to date
0
Altmetric
Review Articles

PRCosomes: pretty reactive complexes formed in liposomes

, , &
Pages 787-796 | Received 25 Feb 2016, Accepted 02 May 2016, Published online: 22 May 2016
 

Abstract

As a tribute to Pieter R. Cullis, this manuscript identifies a liposomal formulation that bears his initials: the PRCosomes. “Pretty” Reactive Complexes within liposomes were observed, while the senior author of this manuscript completed his Ph.D. thesis under Pieter’s supervision. The dye (safranine) was used as a tool to measure the magnitude of the transmembrane gradient generated with liposomes. The dye’s redistribution is easily detected by eye and correlates with >98% encapsulation of the dye. This observation became the basis from which remote drug loading methods developed. Remote loading methodology involves the addition of drugs to pre-formed liposomes with a transmembrane gradient, which results in drug redistribution to the liposome interior. Doxorubicin, as an example drug candidate, complexes manganese trapped within the liposome. A color change accompanied drug encapsulation as the solution went from an orange to purple. This manuscript reviews and adds a novel perspective on the use of metal complexation reactions to prepare PRCosomes. The technology described provides a versatile method to form metal–drug complexed within liposomes. The purpose of this work is to differentiation between drug candidate loading that is caused by metal–drug complexation and loading driven by formation of a pH gradient.

Disclosure statement

The authors declare no competing financial interests and no conflict of interest related to manuscript.

Funding information

The research described in this original paper was supported by grant funding from the Canadian Institutes of Health Research (MOP-102611) and the Canadian Cancer Society Research Institute (Award # 702491).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.